WORLD
Invokana Was Johnson & Johnson's Big Bet on the Vast Market for Type 2 Diabetes Drugs. ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Invokana was Johnson & Johnson's big bet on the vast market for type 2 diabetes drugs. While sales soared, @Reuters found, executives rebuffed their safety experts’ advice to warn regulators about a dangerous complication ...'
Invokana was Johnson & Johnson's big bet on the vast market for type 2 diabetes drugs. While sales soared, @Reuters found, executives rebuffed their safety experts’ advice to warn regulators about a dangerous complication https://t.co/hMP8EZf4VE pic.twitter.com/gCB1YCxeo5— Reuters (@Reuters) December 8, 2021
(The above story first appeared on LatestLY on Dec 08, 2021 11:36 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
